Misplaced Pages

Psychosis

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Joelr31 (talk | contribs) at 19:27, 25 October 2006 (no longer FA). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 19:27, 25 October 2006 by Joelr31 (talk | contribs) (no longer FA)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) For the professional wrestler known as Psychosis, see Dionicio Castellanos. Medical condition
Psychosis
SpecialtyPsychiatry, clinical psychology Edit this on Wikidata

Psychosis is a generic psychiatric term for a mental state in which thought and perception are severely impaired. Persons experiencing a psychotic episode may experience hallucinations, hold delusional beliefs (e.g., grandiose or paranoid delusions), demonstrate personality changes and exhibit disorganized thinking (see thought disorder). This is often accompanied by lack of insight into the unusual or bizarre nature of such behavior, difficulties with social interaction and impairments in carrying out the activities of daily living. A psychotic episode is often described as involving a "loss of contact with reality".

Classification

Psychosis is considered by mainstream psychiatry to be a symptom of severe mental illness, but is not a diagnosis in itself. Although it is not exclusively linked to any particular psychological or physical state, it is particularly associated with schizophrenia, bipolar disorder (manic depression) and severe clinical depression. There are also detectable physical pathologies that can induce a psychotic state, including brain injury or other neurological disorder, drug intoxication and withdrawal (especially alcohol, barbiturates, and sometimes benzodiazepines), lupus, electrolyte disorders such as hypocalcemia, hypernatremia, hyponatremia, hypokalemia, hypomagnesemia, hypermagnesemia, hypercalcemia, and hypophosphatemia.

The term psychosis should be distinguished from the concept of insanity, which is a legal term denoting that a person should not be criminally responsible for his actions. Similarly, it should be distinguished from psychopathy, a personality disorder often associated with violence, lack of empathy and socially manipulative behavior. Despite the fact that both are colloquially abbreviated to "psycho", psychosis bears little similarity to psychopathy's core features, particularly with regard to violence, which rarely occurs in psychosis, and the distortion of perceived reality, which rarely occurs in psychopathy.

Psychosis should also be distinguished from the state of delirium, in that a psychotic individual may be able to perform actions that require a high level of intellectual effort in clear consciousness. Finally, it should be distinguished from mental illness in general. Psychosis may be regarded as a symptom of other mental illnesses, but as a descriptive concept it is not considered an illness in its own right. For example, persons with schizophrenia can have long periods without psychosis, and persons with bipolar disorder and depression can have mood symptoms without psychosis. Conversely, psychosis can occur in persons without chronic mental illness, as a result of an adverse drug reaction or extreme stress.

Causes

Psychotic states occurring after drug use may be particularly linked to drug overdose, chronic use and drug withdrawal. Certain compounds may be more likely to induce psychosis and some individuals may show greater sensitivity than others. Certain "street" drugs, such as cocaine, amphetamines, PCP and hallucinogens are particularly linked to the development of psychosis. Anticholinergic drugs (atropine, scopolamine, Jimson weed), and many antihistamines can also induce psychosis at high enough dosages.

Intoxication with drugs that have general depressant effects on the central nervous system (especially alcohol and barbiturates) tend not to cause psychosis during use, and can actually decrease or lessen the impact of symptoms in some people. Withdrawal from barbiturates and alcohol can be particularly dangerous, however, leading to psychosis or delirium and other, potentially lethal, withdrawal effects.

Psychosis can be a feature of several diseases, often when the brain or nervous system is directly affected. However, the fact that psychosis can occasionally arise in parallel with a number of ailments (including diseases such as flu or mumps for example) suggests that a variety of nervous system stressors can lead to a psychotic reaction. Psychosis arising from non-psychiatric conditions is sometimes known as 'secondary psychosis'. The mechanisms by which this happens are still not clear, but the non-specificity of psychosis has led Tsuang and colleagues to argue that "psychosis is the 'fever' of mental illness—a serious but nonspecific indicator".

Non-psychiatric conditions which are particularly linked to psychosis include brain tumour, dementia with Lewy bodies, hypoglycemia, intoxication, multiple sclerosis, Systemic Lupus Erythematosus, sarcoidosis,, mumps, AIDS, malaria, and leprosy.

Psychological stress is also known to contribute to and trigger psychotic states. Both a history of traumatic incidents experienced throughout the life-span, and the recent experience of a stressful event, is thought to contribute to the development of psychosis. Short-lived psychosis triggered by stress is known as brief reactive psychosis, so patients may spontaneously recover normal functioning within two weeks. In some rare cases, individuals may remain in a state of full-blown psychosis for many years, or perhaps have attenuated psychotic symptoms (such as low intensity hallucinations) present at most times.

Sleep deprivation has been linked to psychosis, although there is little evidence to suggest that it is a major risk factor in the majority of people. Some people experience hypnagogic or hypnopompic hallucinations, where unusual sensory experiences or thoughts appear during waking or drifting off to sleep. These are normal sleep phenomena, however, and are not considered signs of psychosis.

Signs and symptoms

This section does not cite any sources. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. (Learn how and when to remove this message)

A psychotic episode can be significantly affected by mood. For example, people experiencing a psychotic episode in the context of depression may experience persecutory or self-blaming delusions or hallucinations, while people experiencing a psychotic episode in the context of mania may form grandiose delusions or have an experience of deep religious significance.

Although usually distressing and regarded as an illness process, some people who experience psychosis find beneficial aspects and value the experience or revelations that stem from it.

Hallucinations

Hallucinations are defined as sensory perception in the absence of external stimuli. They are different from illusions, which are the misperception of external stimuli. Hallucinations may occur in any of the five senses and take on almost any form, which may include simple sensations (such as lights, colors, tastes, smells) to more meaningful experiences such as seeing and interacting with fully formed animals and people, hearing voices and complex tactile sensations.

Auditory hallucinations, particularly the experience of hearing voices, are a common and often prominent feature of psychosis. Hallucinated voices may talk about, or to the person, and may involve several speakers with distinct personas. Auditory hallucinations tend to be particularly distressing when they are derogatory, commanding or preoccupying. However, the experience of hearing voices need not always be a negative one. Research has shown that the majority of people who hear voices are not in need of psychiatric help. The Hearing Voices Movement has subsequently been created to support voice hearers, regardless of whether they are considered to have a mental illness or not.

Delusions and paranoia

Psychosis may involve delusional or paranoid beliefs. Karl Jaspers classified psychotic delusions into primary and secondary types. Primary delusions are defined as arising out-of-the-blue and not being comprehensible in terms of normal mental processes, whereas secondary delusions may be understood as being influenced by the person's background or current situation (i.e. ethnic or sexual descrimination, religious, superstitious belief).

Thought disorder

Formal thought disorder describes an underlying disturbance to conscious thought and is classified largely by its effects on speech and writing. Affected persons may show pressure of speech (speaking incessantly and quickly), derailment or flight of ideas (switching topic mid-sentence or inappropriately), thought blocking, and rhyming or punning.

Lack of insight

One important and puzzling feature of psychosis is usually an accompanying lack of insight into the unusual, strange, or bizarre nature of the person's experience or behaviour. Even in the case of an acute psychosis, sufferers may be completely unaware that their vivid hallucinations and impossible delusions are in any way unrealistic. This is not an absolute, however; insight can vary between individuals and throughout the duration of the psychotic episode.

It was previously believed that lack of insight was related to general cognitive dysfunction or to avoidant coping style. Later studies have found no statistical relationship between insight and cognitive function, either in groups of people who only have schizophrenia, or in groups of psychotic people from various diagnostic categories.

In some cases, particularly with auditory and visual hallucinations, the patient has good insight, which makes the psychotic experience even more terrifying because the patient realizes that he or she should not be hearing voices, but is.

Pathophysiology

It has also been argued that psychosis exists on a continuum as everybody may have some unusual and potentially reality-distorting experiences in their life. This has been backed up by research showing that experiences such as hallucinations have been experienced by large numbers of the population who may never be impaired or even distressed by their experiences. In this view, people who are diagnosed with a psychotic illness may simply be one end of a spectrum where the experiences become particularly intense or distressing (see schizotypy).

Brain function

The first brain image of a person with psychosis was completed as far back as 1935 using a technique called pneumoencephalography (a painful and now obsolete procedure where cerebrospinal fluid is drained from around the brain and replaced with air to allow the structure of the brain to show up more clearly on an X-ray picture).

Modern brain imaging studies, investigating both changes in brain structure and changes in brain function of people undergoing psychotic episodes, have shown mixed results.

A 2003 study investigating structural changes in the brains of people with psychosis showed there was significant grey matter reduction in the cortex of people before and after they became psychotic. Findings such as these have led to debate about whether psychosis is itself neurotoxic and whether potentially damaging changes to the brain are related to the length of psychotic episode. Recent research has suggested that this is not the case although further investigation is still ongoing.

Functional brain scans have revealed that the areas of the brain that react to sensory perceptions are active during psychosis. For example, a PET or fMRI scan of a person who claims to be hearing voices may show activation in the auditory cortex, or parts of the brain involved in the perception and understanding of speech.

On the other hand, there is not a clear enough psychological definition of belief to make a comparison between different people particularly valid. Brain imaging studies on delusions have typically relied on correlations of brain activation patterns with the presence of delusional beliefs.

One clear finding is that persons with a tendency to have psychotic experiences seem to show increased activation in the right hemisphere of the brain. This increased level of right hemisphere activation has also been found in healthy people who have high levels of paranormal beliefs and in people who report mystical experiences. It also seems to be the case that people who are more creative are also more likely to show a similar pattern of brain activation. Some researchers have been quick to point out that this in no way suggests that paranormal, mystical or creative experiences are in any way by themselves a symptom of mental illness, as it is still not clear what makes some such experiences beneficial whilst others lead to the impairment or distress of diagnosable mental pathology. However, people who have profoundly different experiences of reality or hold unusual views or opinions have traditionally held a complex role in society, with some being viewed as kooks, whilst others are lauded as prophets or visionaries.

Psychosis has been traditionally linked to the neurotransmitter dopamine. In particular, the dopamine hypothesis of psychosis has been influential and states that psychosis results from an overactivity of dopamine function in the brain, particularly in the mesolimbic pathway. The two major sources of evidence given to support this theory are that dopamine-blocking drugs (i.e. antipsychotics) tend to reduce the intensity of psychotic symptoms, and that drugs which boost dopamine activity (such as amphetamine and cocaine) can trigger psychosis in some people (see amphetamine psychosis).

The connection between dopamine and psychosis is generally believed to be complex. First of all, while antipsychotic drugs immediately block dopamine receptors, they usually take a week or two to reduce the symptoms of psychosis. Moreover, newer and equally effective antipsychotic drugs actually block slightly less dopamine in the brain than older drugs whilst also affecting serotonin function, suggesting the 'dopamine hypothesis' is vastly oversimplified. Also, Soyka and colleagues found no evidence of dopaminergic dysfunction people with alcohol-induced psychosis and Zoldan et al reported on the use of ondansetron, a 5-HT3 receptor antagonist, in the treatment of levodopa psychosis in Parkinson's disease patients (they were moderately successful).

Psychiatrist David Healy has criticised pharmaceutical companies for promoting simplified biological theories of mental illness that seem to imply the primacy of pharmaceutical treatments while ignoring social and developmental factors which are known to be important influences in the aetiology of psychosis.

Some theories regard many psychotic symptoms to be a problem with the perception of ownership of internally generated thoughts and experiences. For example, the experience of hearing voices may arise from internally generated speech that is mislabeled by the psychotic person as coming from an external source.

Cannabis

There is growing evidence for a small but significant link between cannabis use and vulnerability to psychosis. Some studies indicate that cannabis use correlates with a slight increase in psychotic experience, which may help trigger full-blown psychosis in some people. Early studies have been criticized for failing to consider other drugs (such as LSD) that the participants may also have used before or during the study, as well as other factors such as possible pre-existing mental health issues. However, more recent studies with better controls have still found a small increase in risk for psychosis in cannabis users. It is not clear whether this is a causal link, and it may be that cannabis use only increases the chance of psychosis in people already predisposed to it. Additionally, people with developing psychosis possibly make greater use of the drug to provide temporary relief to their mental discomfort. The fact that cannabis use has increased over the past few decades, whereas the rate of psychosis has not, suggests that a direct causal link is unlikely for all users.

Treatment

The treatment of psychosis often depends on what associated diagnosis (such as schizophrenia or bipolar disorder) is thought to be present. However, the first line treatment for psychotic symptoms is usually antipsychotic medication, and in some cases hospitalisation. There is growing evidence that cognitive behavior therapy and family therapy can be effective in managing psychotic symptoms. When other treatments for psychosis are ineffective, electroconvulsive therapy (ECT) (aka shock treatment) is sometimes utilized to relieve the underlying symptoms of psychosis, such as depression or schizophrenia. Antipsychotic medication is usually the first line treatment for psychosis and can potentially minimize or eliminate the symptoms within a relatively rapid amount of time.

History

The word psychosis was first used by Ernst von Feuchtersleben in 1845 as an alternative to insanity and mania and stems from the Greek psyche (mind) and -osis (diseased or abnormal condition). The word was used to distinguish disorders which were thought to be disorders of the mind, as opposed to neurosis, which was thought to stem from a disorder of the nervous system.

The division of the major psychoses into manic depressive insanity (now called bipolar disorder) and dementia praecox (now called schizophrenia) was made by Emil Kraepelin, who attempted to create a synthesis of the various mental disorders identified by 19th century psychiatrists, by grouping diseases together based on classification of common symptoms. Kraepelin used the term 'manic depressive insanity' to describe the whole spectrum of mood disorders, in a far wider sense than it is usually used today. In Kraepelin's classification this would include 'unipolar' clinical depression, as well as bipolar disorder and other mood disorders such as cyclothymia. These are characterised by problems with mood control and the psychotic episodes appear associated with disturbances in mood, and patients will often have periods of normal functioning between psychotic episodes even without medication. Schizophrenia is characterized by psychotic episodes which appear to be unrelated to disturbances in mood, and most non-medicated patients will show signs of disturbance between psychotic episodes.

During the 1960s and 1970s, psychosis was of particular interest to counterculture critics of mainstream psychiatric practice, who argued that it may simply be another way of constructing reality and is not necessarily a sign of illness. For example, R. D. Laing argued that psychosis is a symbolic way of expressing concerns in situations where such views may be unwelcome or uncomfortable to the recipients. He went on to say that psychosis could be also seen as a transcendental experience with healing and spiritual aspects. Thomas Szasz focused on the social implications of labelling people as psychotic; a label he argues unjustly medicalises different views of reality so such unorthodox people can be controlled by society.

Generally, however, advances in both diagnosis and the scientific study of psychosis have led to theories drawing on biology, cognitive psychology and neuropsychology being accepted as mainstream explanations. In the United States and Europe, few reputable practitioners since the 1990s have approached psychosis outside this scientific frame of reference.

Social impact

This section needs expansion. You can help by adding to it.

Notable cases

This section needs expansion. You can help by adding to it.

Personal accounts

See also

Personal accounts

References

  1. ^ Tsuang, Ming T. (2000). "Toward Reformulating the Diagnosis of Schizophrenia". American Journal of Psychiatry. 157 (7): 1041–1050. PMID 10873908. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  2. Soyka, Michael (1990). "Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia". Acta Psychiatrica Scandanavica. 81 (3): 255–9. PMID 2343749. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. Gossman, William (November 19, 2005). "Delirium Tremens". eMedicine. WebMD. {{cite web}}: Unknown parameter |accessmonthday= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help)
  4. de Paola, Luciano (2004). "Bizarre behavior during intracarotid sodium amytal testing (Wada test): Are they predictable?". Arquivos de Neuro-Psiquiatria. 62 (2B): 444–448. doi:10.1590/S0004-282X2004000300012. PMID 15273841. Retrieved 2006-10-15. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  5. Sarrecchia, C. (1998). "". Annali Italiani di Medicina Interna. 13 (4): 237–239. PMID 10349206. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  6. White, M. C. (1982). "Psychosis associated with clonazepam therapy for blepharospasm". Journal of Nervous and Mental Disease. 170 (2): 117–9. PMID 7057171. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  7. Jaffe, R. (1986). "Clonazepam withdrawal psychosis". Journal of Clinical Psychopharmacology. 6 (3): 193. PMID 3711371. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  8. Hallberg, R. J. (1964). "KORSAKOFF-LIKE PSYCHOSIS ASSOCIATED WITH BENZODIAZEPINE OVERDOSAGE" (PDF). American Journal of Psychiatry. 121 (2): 188–189. doi:10.1176/appi.ajp.121.2.188. PMID 14194223. Retrieved 2006-10-15. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  9. ^ Robert, M. (2006). "Neuropsychiatric manifestations systemic lupus erythematosus: A study from South India". Neurology India. 54 (1): 75–77. PMID 16679649. Retrieved 2006-09-29. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  10. Rossman, Phillip L. (1956). "Postpartum Tetany and Psychosis Due to Hypocalcemia" (PDF). California Medicine. 85 (3): 190–193. PMID 13356186. Retrieved 2006-10-16. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  11. Jana, D. K. (1973). "Hypernatremic psychosis in the elderly: case reports". Journal of the American Geriatrics Society. 21 (10): 473–477. PMID 4729012. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  12. Haensch, C. A. (1996). "". Der Nervenarzt. 67 (4): 319–322. PMID 8684511. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  13. Hafez, H. (1984). "Hypokalemia-induced psychosis in a chronic schizophrenic patient". Journal of Clinical Psychiatry. 45 (6): 277–279. PMID 6725222. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  14. Konstantakos, Anastasios K. (May 25, 2006). "Hypomagnesemia". eMedicine. WebMD. {{cite web}}: Check date values in: |date= (help); Unknown parameter |accessmonthday= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  15. Velasco, P. Joel (1999). "Psychiatric Aspects of Parathyroid Disease". Psychosomatics. 40 (6): 486–490. PMID 10581976. Retrieved 2006-10-17. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  16. Rosenthal, M. (1997). "Primary hyperparathyroidism: neuropsychiatric manifestations and case report". Israel Journal of Psychiatry and Related Sciences. 34 (2): 122–125. PMID 9231574. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  17. Nanji, A. A. (1984). "The psychiatric aspect of hypophosphatemia". Canadian Journal of Psychiatry. 29 (7): 599–600. PMID 6391648. {{cite journal}}: Unknown parameter |month= ignored (help)
  18. Hare, R. D. Psychopathy and Antisocial Personality Disorder: A Case of Diagnostic Confusion, Psychiatric Times, February 1996, XIII, Issue 2 Accessed June 26, 2006
  19. Milton, John (2001). "Aggressive incidents in first-episode psychosis". British Journal of Psychiatry. 178: 433–440. PMID 11331559. Retrieved 2006-10-21. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  20. Foley, Sharon R. (January 1, 2005). "Incidence and clinical correlates of aggression and violence at presentation in patients with first episode psychosis". Schizophrenia Research. 72 (2–3): 161–168. doi:10.1016/j.schres.2004.03.010. PMID 15560961. Retrieved 2006-10-21. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  21. Nestor, Paul G. (2002). "Psychosis, Psychopathy, and Homicide: A Preliminary Neuropsychological Inquiry". American Journal of Psychiatry. 159 (1): 138–140. PMID 11772704. Retrieved 2006-10-21. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  22. ^ Jauch, D. A. (1988). "Reactive psychosis. I. Does the pre-DSM-III concept define a third psychosis?". Journal of Nervous and Mental Disease. 176 (2): 72–81. PMID 3276813. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  23. Brady, K. T. (1991). "Cocaine-induced psychosis". Journal of Clinical Psychiatry. 52 (12): 509–512. PMID 1752853. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  24. Reynolds, Lindsay M. (March 1, 2005). "Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain". Schizophrenia Research. 73 (2–3): 147–152. doi:10.1016/j.schres.2004.02.003. PMID 15653257. Retrieved 2006-09-29. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  25. Bergman, K. R. "Atropine-induced psychosis. An unusual complication of therapy with inhaled atropine sulfate" (Infotrieve). Chest. 78 (6): 891–893. PMID 7449475. Retrieved 2006-10-15. {{cite journal}}: Missing pipe in: |coauthors= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  26. Varghese, S. (1990). "Ocular atropine induced psychosis--is there a direct access route to the brain?". Journal of the Association of Physicians of India. 38 (6): 444–445. PMID 2384469. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  27. Barak, Segev (September 13, 2006). "Scopolamine Induces Disruption of Latent Inhibition Which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor". Neuropsychopharmacology. doi:10.1038/sj.npp.1301208. PMID 16971898. Retrieved 2006-10-15. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  28. Kurzbaum, Alberto (2001). "Toxic Delirium due to Datura Stramonium" (PDF). Israel Medical Association Journal. 3 (7): 538–539. PMID 11791426. Retrieved 2006-10-17. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  29. Sexton, J. D. (1997). "Diphenhydramine-induced psychosis with therapeutic doses". American Journal of Emergency Medicine. 15 (5): 548–549. PMID 9270406. Retrieved 2006-09-29. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  30. Lang, K. (December 8, 1995). "". Deutsche medizinische Wochenschrift. 120 (49): 1695–1698. PMID 7497894. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  31. Schreiber, W. (February 5, 1988). "". Deutsche medizinische Wochenschrift. 113 (5): 180–183. PMID 3338401. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  32. Timnak, Charles (2004). "Promethazine-Induced Psychosis in a 16-Year-Old Girl". Psychosomatics. 45 (1): 89–90. PMID 14709767. Retrieved 2006-09-29. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  33. Steinberg, D. (1972). "Influenza infection causing manic psychosis". British Journal of Psychiatry. 120 (558): 531–535. PMID 5041533. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  34. Maurizi, C. P. (1985). "Influenza and mania: a possible connection with the locus ceruleus". Southern Medical Journal. 78 (2): 207–209. PMID 3975719. {{cite journal}}: Unknown parameter |month= ignored (help)
  35. Keddie, K. M. (1965). "Toxic psychosis following mumps". British Journal of Psychiatry. 111: 691–696. PMID 14337417. {{cite journal}}: Unknown parameter |month= ignored (help)
  36. Lisanby, S. H. (1998). "Psychosis Secondary to Brain Tumor". Seminars in clinical neuropsychiatry. 3 (1): 12–22. PMID 10085187. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  37. McKeith, Ian G. (2002). "Dementia with Lewy bodies". British Journal of Psychiatry. 180: 144–147. PMID 11823325. Retrieved 2006-09-27. {{cite journal}}: Unknown parameter |month= ignored (help)
  38. Template:Cite online journal
  39. Larson, Michael (2006-03-30). "Alcohol-Related Psychosis". eMedicine. WebMD. {{cite web}}: Unknown parameter |accessmonthday= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help)
  40. Template:Es icon Rodriguez Gomez, Diego (August 16-31, 2005). "Psicosis aguda como inicio de esclerosis multiple / Acute psychosis as the presenting symptom of multiple sclerosis / Psicose aguda como inicio de esclerose multipla". Revista de Neurología. 41 (4): 255–256. PMID 16075405. Retrieved 2006-09-27. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  41. Bona, Joseph R. (1998). "Neurosarcoidosis as a Cause of Refractory Psychosis: A Complicated Case Report". American Journal of Psychiatry. 155 (8): 1106–1108. PMID 9699702. Retrieved 2006-09-29. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  42. DeLage, J. (1955). "". Laval Médical. 20 (2): 175–183. PMID 14382616. {{cite journal}}: Unknown parameter |month= ignored (help)
  43. Evans, Dwight L. (2002-02-01). "Chapter 90: Neuropsychiatric Manifestations of HIV-1 Infection and AIDS". In Kenneth L Davis, Dennis Charney, Joseph T Coyle, Charles Nemeroff (ed.). Neuropsychopharmacology: The Fifth Generation of Progress (5th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 1281–1301. ISBN 0781728371. Retrieved 2006-10-16. {{cite book}}: External link in |chapterurl= (help); Unknown parameter |chapterurl= ignored (|chapter-url= suggested) (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)CS1 maint: multiple names: editors list (link)
  44. Tilluckdharry, C. C. (1996). "A case of vivax malaria presenting with psychosis". West Indian Medical Journal. 45 (1): 39–40. PMID 8693739. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  45. Lowinger, Paul (1959). "LEPROSY AND PSYCHOSIS". American Journal of Psychiatry. 116 (1): 32–37. doi:10.1176/appi.ajp.116.1.32. Parameter error in {{PMID}}: Missing PMID.. Retrieved 2006-10-17. {{cite journal}}: Unknown parameter |month= ignored (help)
  46. Ponomareff, G. L. (1965). "PHENOMENOLOGY OF DELUSIONS IN A CASE OF LEPROSY" (PDF). American Journal of Psychiatry. 121 (12): 1211. PMID 14286061. Retrieved 2006-10-17. {{cite journal}}: Unknown parameter |month= ignored (help)
  47. Sharma, Verinder (2003). "Sleep loss and postpartum psychosis". Bipolar Disorders. 5 (2): 98–105. doi:10.1034/j.1399-5618.2003.00015.x. PMID 12680898. Retrieved 2006-09-27. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  48. Chan-Ob, T. (1999). "Meditation in association with psychosis". Journal of the Medical Association of Thailand. 82 (9): 925–930. PMID 10561951. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  49. Devillieres, P. (1996). "". L'Encéphale. 22 (3): 229–231. Parameter error in {{PMID}}: Missing PMID.. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  50. Ohayon, M. M. (1996). "Hypnagogic and hypnopompic hallucinations: pathological phenomena?". British Journal of Psychiatry. 169 (4): 459–467. PMID 8894197. Retrieved 2006-10-21. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  51. Harper, Douglas (2001). "hallucinate". Online Etymology Dictionary. {{cite web}}: Unknown parameter |accessmonthday= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |month= ignored (help)
  52. Honig, A (1998). "Auditory hallucinations: a comparison between patients and nonpatients". Journal of Nervous and Mental Disease. Retrieved 2006-08-19. {{cite web}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  53. Jaspers, Karl (1997-11-27) . Allgemeine Psychopathologie (General Psychopathology). Translated by J. Hoenig & M.W. Hamilton from German (Reprint edtion ed.). Baltimore, Maryland: Johns Hopkins University Press. ISBN 0801857759.
  54. Carpenter, William T., Jr., John S. Strauss, and John J. Bartko (December 21, 1973). "Flexible system for the diagnosis of schizophrenia: Report from the WHO international pilot study of schizophrenia" (PDF). Science. 182 (4118): 1275–1278. doi:10.1126/science.182.4118.1275. PMID 4752222. Retrieved 2006-10-21. {{cite journal}}: Check date values in: |date= (help); External link in |format= (help)CS1 maint: multiple names: authors list (link)
  55. Lysaker, Paul H. (1994). "Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test". Journal of Nervous and Mental Disease. 182 (11): 656–660. PMID 7964675. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  56. Lysaker, Paul H. (January 1, 2003). "Insight in schizophrenia: associations with executive function and coping style". Schizophrenia Research. 59 (1): 41–47. doi:10.1016/S0920-9964(01)00383-8. PMID 12413641. Retrieved 2006-10-22. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  57. Freudenreich, Oliver (2004). "Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect". Acta Psychiatrica Scandinavica. 110 (1): 14–20. doi:10.1111/j.1600-0447.2004.00319.x. PMID 15180775. Retrieved 2006-10-22. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  58. Cuesta, Manuel J. (May 31, 2006). "Insight dimensions and cognitive function in psychosis: a longitudinal study". BMC Psychiatry. 6: 26–35. doi:10.1186/1471-244X-6-26. PMID 16737523. Retrieved 2006-10-22. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)CS1 maint: unflagged free DOI (link)
  59. Johns, Louise C. (2001). "The continuity of psychotic experiences in the general population". Clinical Psychology Review. 21 (8). PubMed: 1125–41. doi:10.1016/S0272-7358(01)00103-9. PMID 11702510. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  60. Moore, M T (1935). "Encephalographic studies in mental disease". American Journal of Psychiatry. 92 (1): 43–67. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  61. Pantelis, C (2003). "Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison". Lancet. 25 (361 (9354)). PubMed: 281–8. PMID 12559861. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  62. Ho, BC (2003). "Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia". American Journal of Psychiatry. 160 (1). PubMed: 142–148. PMID 12505813. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  63. Copolov DL, Seal ML, Maruff P, Ulusoy R, Wong MT, Tochon-Danguy HJ, Egan GF. (2003) Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res, 122 (3), 139-52. PMID 12694889.
  64. Bell, V., Halligan, P.W. & Ellis, H.D. (2006) A Cognitive Neuroscience of Belief. In P.W. Halligan & M. Aylward (eds) The Power of Belief. Oxford: Oxford University Press.
  65. Lohr, JB (1997). "Lateralized hemispheric dysfunction in the major psychotic disorders: historical perspectives and findings from a study of motor asymmetry in older patients". Schizophrophrenia Research. 30 (27 (2-3)). PubMed: 191–8. PMID 9416648. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  66. Pizaagalli, D (2000). "Brain electric correlates of strong belief in paranormal phenomena: intracerebral EEG source and regional Omega complexity analyses". Psychiatry Research. 100 (3). PubMed: 139–154. PMID 11120441. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  67. Makarec, K (1985). "Temporal lobe signs: electroencephalographic validity and enhanced scores in special populations". Perceptual and Motor Skills. 60 (3). PubMed: 831–842. PMID 3927256. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  68. Weinstein, S (2002). "Are creativity and schizotypy products of a right hemisphere bias?". Brain and Cognition. 49 (1). PubMed: 138–151. PMID 12027399. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  69. Kapur S, Mizrahi R, Li M. (2005) From dopamine to salience to psychosis - linking biology, pharmacology and phenomenology of psychosis. Schizophr Res, 79 (1), 59-68. PMID 16005191
  70. Jones, H. M., & Pilowsky, L. S. (2002) Dopamine and antipsychotic drug action revisited. British Journal of Psychiatry, 181, 271-275. PMID 12356650
  71. Soyka, Michael (2000). "FDG-PET and IBZM-SPECT Suggest Reduced Thalamic Activity but No Dopaminergic Dysfunction in Chronic Alcohol Hallucinosis". Journal of Neuropsychiatry & Clinical Neurosciences. 12 (2): 287–288. PMID 11001615. Retrieved 2006-10-15. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  72. Zoldan, J. (1995). "Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist". Neurology. 45 (7): 1305–1308. PMID 7617188. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  73. Healy, David (2002). The Creation of Psychopharmacology. Cambridge: Harvard University Press. ISBN 0-674-00619-4. {{cite book}}: Cite has empty unknown parameter: |coauthors= (help)
  74. Blakemore, SJ (2000). "The perception of self-produced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring". Psychological Medicine. 30 (5). PubMed: 1131–9. PMID 12027049. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  75. ^ Degenhardt, L (2003). "Editorial: The link between cannabis use and psychosis: furthering the debate". Psychological Medicine. 33. PubMed: 3–6. PMID 12537030. Retrieved 2006-08-19. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help) Cite error: The named reference "Deg" was defined multiple times with different content (see the help page).
  76. Degenhardt L, Hall W, Lynskey M (2001). "Comorbidity between cannabis use and psychosis: Modelling some possible relationships" (PDF). Technical Report No. 121. Sydney: National Drug and Alcohol Research Centre. Retrieved 2006-08-19. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)
  77. Birchwood, M (2006). "The future of cognitive-behavioural therapy for psychosis: not a quasi-neuroleptic". British Journal of Psychiatry. 188: 108–108. PMID 16449695. {{cite journal}}: |access-date= requires |url= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  78. Haddock, G (2005). "Psychological interventions in early psychosis". Schizophrenia Bulletin. 31 (3): 697–704. PMID 16006594. {{cite journal}}: |access-date= requires |url= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  79. Beer, M D (1995). "Psychosis: from mental disorder to disease concept". Hist Psychiatry. 6 (22(II)). PubMed: 177–200. PMID 11639691. Retrieved 2006-08-19. {{cite journal}}: Cite has empty unknown parameter: |coauthors= (help)
  80. "Online Etymology Dictionary". Douglas Harper. 2001. Retrieved 2006-08-19. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)

Further reading

  • Sims, A. (2002) Symptoms in the mind: An introduction to descriptive psychopathology (3rd edition). Edinburgh: Elsevier Science Ltd. ISBN 0-7020-2627-1

Personal accounts

  • Dick, P.K. (1981) VALIS. London: Gollancz. ISBN 0-679-73446-5
  • Jamison, K.R. (1995) An Unquiet Mind: A Memoir of Moods and Madness. London: Picador.
    ISBN 0-679-76330-9
  • Schreber, D.P. (2000) Memoirs of My Nervous Illness. New York: New York Review of Books. ISBN 0-940322-20-X
  • McLean, R (2003) Recovered Not Cured: A Journey Through Schizophrenia. Allen & Unwin. Australia. ISBN 1-86508-974-5

External links

Categories: